EUVIMEDEUVIMED entdecken
Crossref

Effect of intratympanic steroid injection on hearing loss and tinnitus in sudden sensorineural hearing loss

Rekawt Hama Rashid Kareem, Goran Latif Omer, Giuseppe De Donato, Stefano Di Girolamo, Sahand Soran Ali, Aland Salih Abdullah, Riccardo Maurizi, Gianluca Velletrani, Beatrice Francavilla, Giulia Marzochella

Australian Journal of Otolaryngology · 2025-11 · 8 · 47-47

DOI: 10.21037/ajo-25-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian Journal of Otolaryngology, 2025-11. Verfasst von Rekawt Hama Rashid Kareem und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although spontaneous recovery is possible in sudden sensorineural hearing loss (SSNHL), early intervention is strongly recommended to improve outcomes. Oral corticosteroids are the standard treatment, but their long-term use may lead to significant adverse effects. This study aims to evaluate the efficacy of intratympanic steroid (ITS) injections, especially for ameliorating hearing loss and tinnitus. The regimen is assessed in patients receiving ITS as initial therapy as well as those using it as salvage treatment following prior systemic therapy failure.

Methods

A prospective observational cohort study was conducted between January 2020 and September 2022 at Faruk Medical City (FMC) and a private ear, nose, and throat (ENT) clinic in Sulaymaniyah, Iraq. Adult inpatients diagnosed with SSNHL were included. The cohort comprised two groups: patients who had previously received unsuccessful treatment elsewhere and those who had not received any prior therapy. Each patient received six ITS injections over 6 consecutive days. Additionally, patients completed the Tinnitus Handicap Inventory (THI) at baseline and at the final follow-up. Hearing recovery was classified with Siegel’s criteria.

Results

Of the 48 patients enrolled, 52% were female and 48% male. Participants ranged in age from 16 to 82 years, with a mean age of 45.4±15.5 years. Comorbidities such as diabetes mellitus, hypertension, or both were present in 21% of cases. 46% sought medical care between 2 weeks and 1 month after symptom onset. Audiological evaluation revealed that 35% of patients had profound hearing loss. Post treatment 16 (33%) had complete hearing recovery with 23 (48%) partial recovery. Pre-treatment THI results showed that 38 (79%) of patients had mild to moderate tinnitus. Following treatment, 79% of patients showed significant improvement in tinnitus severity.

Conclusions

The findings suggest that ITS therapy is effective in treating both hearing loss and tinnitus in SSNHL patients. The authors recommend considering ITS not only as a salvage therapy but also as a first-line treatment option.

Zitieren

APA

Kareem, R. H. R., Omer, G. L., Donato, G. D., Girolamo, S. D., Ali, S. S., Abdullah, A. S., Maurizi, R., Velletrani, G., Francavilla, B., & Marzochella, G. (2025). Effect of intratympanic steroid injection on hearing loss and tinnitus in sudden sensorineural hearing loss. Australian Journal of Otolaryngology, 8, 47-47. https://doi.org/10.21037/ajo-25-7

Vancouver

Kareem RHR, Omer GL, Donato GD, Girolamo SD, Ali SS, Abdullah AS, et al. Effect of intratympanic steroid injection on hearing loss and tinnitus in sudden sensorineural hearing loss. Australian Journal of Otolaryngology. 2025;8:47-47. doi:10.21037/ajo-25-7

BibTeX
@article{Kareem2025,
  author = {Kareem, Rekawt Hama Rashid and Omer, Goran Latif and Donato, Giuseppe De and Girolamo, Stefano Di and Ali, Sahand Soran and Abdullah, Aland Salih and Maurizi, Riccardo and Velletrani, Gianluca and Francavilla, Beatrice and Marzochella, Giulia},
  title = {Effect of intratympanic steroid injection on hearing loss and tinnitus in sudden sensorineural hearing loss},
  journal = {Australian Journal of Otolaryngology},
  year = {2025},
  volume = {8},
  pages = {47--47},
  doi = {10.21037/ajo-25-7}
}
Kostenlos starten →